![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
Advertisement
Persons > All
Find below all kinds of persons.Total search results: 7469 | Ordered by Person (ascending)
1 2 3 ... 21 22 23 ... 73 74 75 
  Person |
 Position |
Organisation (Group) |
Country |
|---|---|---|---|
| Goebel, Werner (Universität Würzburg 200504) | n. a. | University of Würzburg | Germany |
| Goedesky, George (Bruker 201009 Exec Director Marketing + BusDev MALDI Biotyper) | Sales Manager / Marketing Manager | Bruker (Group) | United States (USA) |
| Goergen, Bernd (High-Tech Gründerfonds 2007– Senior-Investmentmanager before DZ Bank 2000–2007) | Investment Manager | High-Tech Gründerfonds (HTGF) (Group) | Germany |
| Goetz, Wolfgang (Transcatheter Technologies 201105 CEO) | Chief Executive Officer (CEO) | Transcatheter Technologies GmbH | Germany |
| Goff, Marcia (Thermo Fisher –201805 LEFT) | n. a. | Thermo Fisher (Group) | United States (USA) |
| Gohlke, Rüdiger (GSG Mess- und Analysengeräte 200803 Managing Director) | Managing Director | GSG Mess- und Analysengeräte GmbH | Germany |
| Gohm, Harald (Tirol (govt) 201105 Standortagentur Tirol Managing Director) | Managing Director | Tirol (govt region) | Austria |
| Goig, André (Syngenta 201306 Regional Director EAME + Chairman of EuropaBio since 201306) | Regional manager | Syngenta (Group) | Switzerland |
| Goker, Hakan (Merck (DE) 201509 Senior Investment Direcotor MS Ventures before Aescap Venture + Atlas Venture) | Investment Manager | Merck (DE) (Group) | Germany |
| Gold, Ludwig (Miracor 201407 CEO) | Chief Executive Officer (CEO) | Miracor (Group) | Austria |
| Goldenstein, Lissa (Auxogyn 201210 CEO) | Chief Executive Officer (CEO) | Auxogyn Inc. | United States (USA) |
| Goldman, Jonathan (Aptuit 201604 CEO) | Chief Executive Officer (CEO) | Evotec (Group) | United States (USA) |
| Goldman, Michel (Innovative Medicines Initiative 201103 Executive Director) | President/Director/Head Business Group/Unit/Division | Innovative Medicines Initiative (IMI) | EU (European Union) |
| Goldschmidt, Colin (Sonic Healthcare 201701 CEO + Managing Director) | Chief Executive Officer (CEO) | Sonic Healthcare (Group) | Australia |
| Goldsmith, George (Compass Pathways 202004 CEO + Co-Founder) | Chief Executive Officer (CEO) | Compass Pathways (Group) | United Kingdom (GB) |
| Goldsmith, Neil (Sundew 202009 Chairman before Evolva –200910–201707 CEO STEPPED DOWN 7/17) | Chief Executive Officer (CEO) | Sundew ApS | Denmark |
| Goletz, Steffen (Glycotope 201601– CSO before since 200809 Managing Director + Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Glycotope (Group) | Germany |
| Goll, Alexandra (TVM 200512) | General Partner (venture partner) | TVM (Group) | Germany |
| Golla, Stephan (Univ of Western Sydney 201203) | n. a. | University of Western Sydney (UWS) | Australia |
| Goller, Alexandra (MorphoSys 201803 Associate Director Corp Comm & IR) | Public Relations Manager / Investor Relations Manager | MorphoSys (Group) | Germany |
| Golson, Russell (Biognosys 201401– Director of Sales before BioSilta + Febit + MWG Biotech) | Sales Manager / Marketing Manager | Biognosys AG | Switzerland |
| Golumbeski, George (Celgene 201804 EVP + Executive Advisor for Innovation + proposed to MorphoSys Supervisory Board) | President/Director/Head Business Group/Unit/Division | Bristol-Myers Squibb (BMS) (Group) | United States (USA) |
| Gombert, Till (Protectimmun 200808 Founder) | Company Founder | Protectimmun GmbH | Germany |
| Gonçalves, Dulce (Auven Therapeutics 201409– Corporate Counsel at ADC Therapeutics before Novartis) | General Counsel / Chief Legal Officer (CLO) | ADC Therapeutics (Group) | Switzerland |
| Gonciarz, Grzegorz (Resistell 202007 COO) | Chief Operating Officer (COO) | Resistell AG | Switzerland |
| Gonthiez, Thierry (Resolution Spectra Systems 202007 General Manager + Co-Founder) | General Manager (management) | Merck (DE) (Group) | France |
| Gooch, Daniel (Instinctif Partners 201509) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | United Kingdom (GB) |
| Goodwin, Elizabeth (Galapagos 201112 Director Investor Relations) | Public Relations Manager / Investor Relations Manager | Galapagos (Group) | Belgium |
| Goorden, Bram (Sophia Genetics 202011– CCO + Head North America before Foundation Medicine + Prometheus Labs + Lilly) | Chief Commercial Officer (CCO) | Sophia Genetics (Group) | United States (USA) |
| Gorbachev, Maxim (Russia (govt) 201501 Partner at RMI Partners) | Partner (venture partner) | Russia (govt) | Russian Federation |
| Gordon, Carl L. (OrbiMed Advisors 201509 Partner) | Partner (venture partner) | OrbiMed (Group) | United States (USA) |
| Gordon, Jenn (Global Health PR 201901) | Public Relations Manager / Investor Relations Manager | Global Health PR (US) | United States (USA) |
| Gordon, Steven J. (Intelligent Bio-Systems 201206 CEO + founder) | Chief Executive Officer (CEO) | Qiagen (Group) | United States (USA) |
| Goris, Ludwig (Capricorn Venture Partners 201808 Investment Manager) | Investment Manager | Capricorn Venture Partners (Group) | Belgium |
| Gorman, Kevin (Neurocrine Biosciences 202005 CEO) | Chief Executive Officer (CEO) | Neurocrine Biosciences (Group) | United States (USA) |
| Gorzka, Gabriele (Univ Kassel 201108 Head of OWWZ) | President/Director/Head Business Group/Unit/Division | University of Kassel | Germany |
| Goschin, Jörg (Alstin GmbH 201108– Managing Director before Blackstone Group London + Cerberus Capital) | Managing Director | MASCHMEYER Group (family Maschmeyer) | Germany |
| Gossé, Jörn (Körber 201905 CEO of Körber Medipak Systems) | Chief Executive Officer (CEO) | Körber (Group) | Germany |
| Gotteland, Jean-Pierre (ObsEva 201701 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | ObsEva (Group) | Switzerland |
| Gottraux, Jean-Claude (Roche 201404 Head of Roche Professional Diagnostics) | President/Director/Head Business Group/Unit/Division | Roche (Group) | Switzerland |
| Gottschalk, Gerhard | n. a. | Project »Genomforschung an Mikroorganismen zur Analyse und Nutzung der Biodiversität« (Kompetenznetz, Uni Göttingen) | Germany |
| Gottschalk, Uwe (Lonza 201406– CTO of Lonza Pharma&Biotechbefore Sartorius Stedim Biotech + Bayer Heatlhcare) | Chief Technology/Technical Officer (CTO) | Lonza (Group) | Switzerland |
| Gouliaev, Alex Haahr (Nuevolution 201205 CEO + Co-founder before NeuroSearch) | Chief Executive Officer (CEO) | Nuevolution (Group) | Denmark |
| Goundis, Dimitri (MaxiVax 201602– CEO before Acrongenomics + Speedel + Medicines Co Inc + Roche) | Chief Executive Officer (CEO) | MaxiVax S.A. | Switzerland |
| Goutopoulos, Andreas (Merck (DE) 202004 Senior Scientific Director at EMD Serono + CSO at Metabomed + EiR at M Ventures) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Merck (DE) (Group) | United States (USA) |
| Graber, Armin (Biocrates 200502 Managing Director) | Managing Director | Biocrates (Group) | Austria |
| Grabert, Sebastian (Euronext 201709 Director Germany Representative before HSCBC + Berenberg) | Sales Manager / Marketing Manager | Euronext (Group) | Netherlands |
| Grabulovski, Dragan (Covagen 200701– CSO + co-founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Johnson & Johnson (JnJ) (Group) | Switzerland |
| Gradnik, Roberto (Merck Serono –200708– Head of Operations Europe) | n. a. | Merck (DE) (Group) | Germany |
| Graewe, Thomas (Amedrix 201109 Managing Director) | Managing Director | Amedrix GmbH | Germany |
| Graf von Stosch, Andreas (Bosch Graf von Stosch Jehle 200809) | n. a. | Bosch Graf von Stosch Jehle (Munich) | Germany |
| Graf, Marcus (Geneart 199911– co-founder + 5/06 head Bus Unit gene synthesis) | President/Director/Head Business Group/Unit/Division | Thermo Fisher (Group) | Germany |
| Graf, Peter (Bavaria (govt) 201902 Investment Manager at BayBG) | Investment Manager | Bavaria (govt region) | Germany |
| Graham, John (Menarini 201504 Chief Executive of Menarini Asia-Pacific Pte Ltd) | Chief Executive Officer (CEO) | Menarini (Group) | Singapore |
| Graimann, Bernhard (Otto Bock 201009) | n. a. | Ottobock (Otto Bock) (Group) | Germany |
| Grainger, David (Medixci Ventures 201602– General Partner before Index Ventures 2012– + Funxional Therapeutics) | General Partner (venture partner) | Medicxi Ventures (formerly Index Ventures Life Sciences) | United Kingdom (GB) |
| Gramatica, Ruggero (Therametrics –201309 CEO RESIGNED 9/13) | Chief Executive Officer (CEO) | Relief Therapeutics (Group) | Switzerland |
| Grandidier, Laurent (Xeltis 201412 CEO) | Chief Executive Officer (CEO) | Xeltis (Group) | Switzerland |
| Granese, Don (Sophia Genetics 202002 Media Relations Manager US) | Public Relations Manager / Investor Relations Manager | Sophia Genetics (Group) | United States (USA) |
| Graney, Tom (Oxurion 202010– CFO based in US before Generation Bio + Vertex Pharmaceuticals + Ironwood Pharma + JnJ) | Chief Financial Officer (CFO) | Oxurion (Group) | Belgium |
| Granger, Chris (Immunotec 200508 Director of Sales) | Sales Manager / Marketing Manager | IMMUNOTEC Immunologisch-technische Produkt- und Beratungs GmbH | Germany |
| Granier, Benoit (Unisensor (BE) 201805 CEO) | Chief Executive Officer (CEO) | Unisensor S.A. (BE) | Belgium |
| Grant, Nick (AMETEK 201610 VP Material Analysis Division) | President/Director/Head Business Group/Unit/Division | AMETEK (Group) | United States (USA) |
| Granzer, Ulrich | Venture Partner | Wellington Partners (Group) | Germany |
| Grassauer, Andreas (Marinomed Biotechnologie GmbH 201307 CEO) | Chief Executive Officer (CEO) | Marinomed Biotech AG (VSE: MARI) | Austria |
| Grau, Daniel (Heptares 201111– President Corporate + Commercial Development before Cortia Corp + CombinatoRx) | Business Development Manager / Strategy Manager | Sosei (Group) | United Kingdom (GB) |
| Grau, Michael (Proteros 201405– CFO before Correvio + Ingenium 200502– CFO + MorphoSys) | Chief Financial Officer (CFO) | Proteros (Group) | Germany |
| Grau, Ulrich (Micromet 201106–2012 COO before Lux Biosciences CEO before Enzon 2002–2005 CSO before BASF/Knoll) | Chief Operating Officer (COO) | Amgen (Group) | Germany |
| Grau, Volker (SMS Service für Massenspektrometrie GmbH 2008 Managing Director) | Managing Director | SMS Service für Massenspektrometrie GmbH | Germany |
| Graupner, Stefan | n. a. | University of Bremen | Germany |
| Grawunder, Ulf (NBE Therapeutics 202008– COO + CDO before CEO + Founder before 4-Antibody CSO) | Chief Operating Officer (COO) | NBE Therapeutics AG | Switzerland |
| Gray, Michael (Mike) (Arsanis 201702 CFO + CBO) | Chief Financial Officer (CFO) | Arsanis (Group) | United States (USA) |
| Graziano, John (Trout Group 201609) | Public Relations Manager / Investor Relations Manager | PNC Financial Services (Group) | United States (USA) |
| Gre(h)ling, Frau (Heidelberg Innovation 200504) | n. a. | Heidelberg Innovation (Group) | Germany |
| Green, Eric (Sigma-Aldrich 200604) | n. a. | Merck (DE) (Group) | United States (USA) |
| Green, Nicholas (Coulter Partners 201711 Managing Partner) | Managing Partner | Coulter Partners (The Coulter Partnership Ltd.) | United Kingdom (GB) |
| Green, Nicola (Halesway Ltd 201201– Account Director before Alto Marketing 201110 Account Director, Life Science) | public relations / investor relations | Halesway Ltd. | United Kingdom (GB) |
| Greenwood, James (Jim) (Biotechnology Industry Organization 201407 President + CEO) | Chief Executive Officer (CEO) | BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) | United States (USA) |
| Grego, Jaime (Laboratorios LETI 201401 President) | President/Director/Head Business Group/Unit/Division | Laboratorios LETI (Group) | Spain (España) |
| Grégoire, Sylvie (Shire President Human Genetic Therapies before IDM Pharma + GlycoFi + Biogen + Merck & Co) | n. a. | Takeda (Group) | Ireland, Republic of |
| Gregory, Philip (Bluebird Bio 201805 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Bluebird Bio (Group) | United States (USA) |
| Greiner, Axel (Greiner 200804 CEO) | Chief Executive Officer (CEO) | Greiner (Group) | Austria |
| Greiner, Boris (Greiner 200804 CEO) | Chief Executive Officer (CEO) | Greiner (Group) | Austria |
| Greiner, Erich F. (Cedrus Therapeutics 201704 before Evotec 200604) | n. a. | Cedrus Therapeutics (Group) | Germany |
| Greiner, Peter (Greiner 200809 Managing Director) | Managing Director | Greiner (Group) | Austria |
| Greshake, Dirk (AstraZeneca 201305– Managing Director at AstraZeneca GmbH) | Managing Director | AstraZeneca (Group) | Germany |
| Greubel, Rick (Kaiima 201707 CEO) | Chief Executive Officer (CEO) | Kaiima Bio-Agritech Ltd. | Israel |
| Greuel, Joachim M. (Bioscience Valuation BSV GmbH 20203 Managing Director) | Managing Director | Bioscience Valuation BSV GmbH | Germany |
| Greving, Matthew (Nextval 201210 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Nextval Inc. | United States (USA) |
| Grewing, Thomas (Anchor Diagnostics 201508 Qiagen 200603 Director RnD Assay Development) | Managing Director | Anchor Diagnostics GmbH | Germany |
| Gribbon, Philip (European ScreeningPort 200810 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Fraunhofer (Group) | Germany |
| Griebel, Ralf (Tecan 202102 Head Partnering Business) | Business Development Manager / Strategy Manager | Tecan (Group) | Switzerland |
| Griesbeck, Oliver (Max Planck Institute for Biochemistry 200808) | n. a. | Max Planck Society for the Advancement of Science | Germany |
| Griesinger, Christian (Max Planck 1999– Director + Scientific Member MPIBPC Göttingen before Univ Frankfurt Professor) | Professor | University of Frankfurt (Goethe-Universität) | |
| Griess, Eike (LGC Promochem GmbH 200502) | n. a. | LGC (Group) | Germany |
| Griffin, Conor (Hume Brophy 201802 Managing Director International Healthcare) | Managing Director | Hume Brophy Communications | United Kingdom (GB) |
| Griffin, Cora (DelSiTech 201609 Business Development Director) | Business Development Manager / Strategy Manager | DelSiTech Ltd. (FI) | Finland |
| Griffiths, David (LGC 201704 Managing Director of LGC LMS division) | Managing Director | LGC (Group) | United Kingdom (GB) |
| Griffiths, Jane (JnJ 201706– Global Head of Actelion) | President/Director/Head Business Group/Unit/Division | Johnson & Johnson (JnJ) (Group) | Switzerland |
| Grillari, Johannes (Evercyte GmbH 201309 CSO + Co-founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Evercyte GmbH | Austria |
1 2 3 ... 21 22 23 ... 73 74 75
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
![Picture [iito] No Content Marketing 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-no-content-marketing.jpg)
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
